Yan Li, Ya Chu, Guangjiang Shi, Xiaobin Wang, Wanli Ye, Chun Shan, . . . Hongxi Wu. (2022). A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer. Elsevier.
Chicago Style (17th ed.) CitationYan Li, et al. A Novel Inhibitor of ARfl and ARv7 Induces Protein Degradation to Overcome Enzalutamide Resistance in Advanced Prostate Cancer. Elsevier, 2022.
MLA (9th ed.) CitationYan Li, et al. A Novel Inhibitor of ARfl and ARv7 Induces Protein Degradation to Overcome Enzalutamide Resistance in Advanced Prostate Cancer. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.